Status:
NOT_YET_RECRUITING
the SDMEAI Study: a Multi-center Epidemiological Study
Lead Sponsor:
Sun Yat-sen University
Conditions:
Eye Involvement of Systemic Diseaes
Adverse Drug Effect on Eye
Eligibility:
All Genders
6-80 years
Brief Summary
A variety of diseases in the Department of Rheumatology, Immunology, Nephrology, and Gastroenterology can cause eye lesions, and medications can also bring various adverse reactions, which can serious...
Eligibility Criteria
Inclusion
- Age 6-80 years old, gender is not limited
- patients who have been diagnosed with systemic diseases;
- patients who have ever or never used any ocular toxic drugs such as corticosteroids, chloroquine, etc.;
- no history of glaucoma, cataract, scleritis, uveitis, ocular trauma, etc. before enrollment;
- willing to complete follow-ups for at least 2 years.
Exclusion
- Mainly use local therapies (intraocular, intra-articular and other non-systemic drug routes);
- history of intraocular surgery (such as lens implantation, vitrectomy, retinal photocoagulation);
- history of glaucoma, cataract, center serous retinopathy, etc.;
- history of various diseases (such as scleritis, uveitis, eye trauma, etc.) that may cause opacity of the eye under the posterior capsule;
- any other diseases or conditions that affect the observation, such as diabetes, low calcium convulsions, long-term exposure to radiation before enrollment;
- subjects with endogenous corticosteroids, or psychiatric diseases.
Key Trial Info
Start Date :
April 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 22 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04849819
Start Date
April 22 2021
End Date
April 22 2026
Last Update
April 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.